V-ATPase activity involves different cellular mechanisms in prostate cancer and its inhibition implies impairment of the apoptosis process and cell cycle, and variation in prostate-specific antigen (PSA) levels and expression [47]. The gene discussed is KLK3; the disease is prostate carcinoma.